We sit down and discuss the effects of big data brokers within the health care industry. What kind of data are they collecting and to whom does this data go to? Who are the companies and individuals involved? Also, was the spike protein intentionally chosen? Why was it chosen? For what purpose? And, the Rwanda scheme gets halted from the UK. Was it ever meant to work to begin with? Or just another tool of leverage to generate conflict with opposing agendas? We ask the questions.
